TWO SIGMA ADVISERS, LP - SATSUMA PHARMACEUTICALS INC ownership

SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 46 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$191,389
+39.6%
274,000
+79.9%
0.00%
Q4 2022$137,070
-34.4%
152,300
+337.6%
0.00%
-100.0%
Q3 2022$209,000
+34.0%
34,800
-7.4%
0.00%
Q2 2022$156,000
-38.3%
37,600
-43.5%
0.00%
-100.0%
Q1 2022$253,000
-36.1%
66,600
-24.3%
0.00%0.0%
Q4 2021$396,000
-37.1%
88,000
-35.0%
0.00%
-50.0%
Q3 2021$630,000
-51.0%
135,300
-25.9%
0.00%
-33.3%
Q2 2021$1,287,000
-2.0%
182,500
-17.9%
0.00%
-25.0%
Q1 2021$1,313,000
+47.9%
222,200
+15.3%
0.00%
+100.0%
Q4 2020$888,000
+5.2%
192,700
-11.2%
0.00%0.0%
Q3 2020$844,000217,0000.00%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 3,118,761$14,533,0003.83%
Ghost Tree Capital, LLC 904,225$4,214,0001.23%
RA Capital Management 5,914,252$27,560,0000.38%
Vivo Capital, LLC 1,232,394$5,743,0000.26%
Nan Fung Group Holdings Ltd 142,900$666,0000.21%
Ikarian Capital, LLC 629,384$2,934,0000.21%
NEA Management Company, LLC 3,142,958$14,646,0000.17%
SAMLYN CAPITAL, LLC 1,716,067$7,998,0000.11%
TPG Group Holdings (SBS) Advisors, Inc. 1,885,939$8,788,0000.09%
GSA CAPITAL PARTNERS LLP 90,665$422,0000.04%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders